Richard A Hartz

9PUBLICATIONS
15CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical virologyBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 20, 2024
Invention of VH-937, a Potent HIV-1 Maturation Inhibitor with the Potential for Infrequent Oral Dosing in Humans.

Sing-Yuen Sit, Yan Chen, Jie Chen

|Oct 26, 2024
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.

Brian McAuliffe, Paul Falk, Jie Chen

|May 26, 2023
Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors.

Richard A Hartz, Vijay T Ahuja, Guanglin Luo

|Mar 23, 2023
Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.

Richard A Hartz, Vijay T Ahuja, Prasanna Sivaprakasam

|Nov 28, 2022
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum Activity.

Richard A Hartz, Li Xu, Sing-Yuen Sit

|Aug 31, 2022
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation.

Alicia Regueiro-Ren, Sing-Yuen Sit, Yan Chen

Pageof 2

Frequent Collaborators

5 joint publications

Alicia Regueiro-Ren

4 joint publications

Nicholas A Meanwell

3 joint publications

Li Xu

2 joint publications

Kaushik Ghosh